author-photo

Xuekai Zhu

ShanghaiTech University

9

Papers

63

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

IKZF3 deficiency potentiates chimeric antigen receptor T cells targeting solid tumors.

2022 Cancer Letters
Show All
- Source
- Cite
- Save
Citations (0)
Circulating miR-221/222 reduces CD4+ T cells by inhibiting CD4 expression in colorectal cancer.

2021 Acta Biochimica et Biophysica Sinica
Show All
- Source
- Cite
- Save
Citations (0)
BAY 60-6583 Enhances the Antitumor Function of Chimeric Antigen Receptor-Modified T Cells Independent of the Adenosine A2b Receptor.

2021 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (1)
Avidity‐Based Selection of Tissue‐Specific CAR‐T Cells from a Combinatorial Cellular Library of CARs

2021 Advanced Science
Show All
- Source
- Cite
- Save
Citations (0)
Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer.

2021 Cancer Letters
Show All
- Source
- Cite
- Save
Citations (0)
Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells

2019 Human Gene Therapy
Show All
- Source
- Cite
- Save
Citations (56)
Next-generation sequencing technologies accelerate advances in T-cell therapy for cancer

2019 Briefings in Functional Genomics
Show All
- Source
- Cite
- Save
Citations (2)
Nucleofection with plasmid DNA for CRISPR/Cas9-mediated inactivation of PD-1 in CD133-specific CAR T Cells

2018
Show All
- Source
- Cite
- Save
Citations (0)